REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 480 filers reported holding REPLIGEN CORP in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,217,857 | +20.3% | 7,659 | +7.0% | 0.00% | 0.0% |
Q2 2023 | $1,012,570 | -16.0% | 7,158 | 0.0% | 0.00% | -20.0% |
Q1 2023 | $1,205,120 | -0.6% | 7,158 | 0.0% | 0.01% | +25.0% |
Q4 2022 | $1,211,920 | +6.3% | 7,158 | +17.4% | 0.00% | -20.0% |
Q3 2022 | $1,140,000 | -30.4% | 6,095 | -39.6% | 0.01% | -28.6% |
Q2 2022 | $1,639,000 | -13.6% | 10,095 | 0.0% | 0.01% | +16.7% |
Q1 2022 | $1,898,000 | -24.7% | 10,095 | +6.1% | 0.01% | -25.0% |
Q4 2021 | $2,519,000 | -8.4% | 9,515 | 0.0% | 0.01% | -20.0% |
Q3 2021 | $2,749,000 | +44.8% | 9,515 | 0.0% | 0.01% | +42.9% |
Q2 2021 | $1,899,000 | +2.7% | 9,515 | 0.0% | 0.01% | -12.5% |
Q1 2021 | $1,849,000 | +8.0% | 9,515 | +6.5% | 0.01% | 0.0% |
Q4 2020 | $1,712,000 | +29.9% | 8,935 | 0.0% | 0.01% | +14.3% |
Q3 2020 | $1,318,000 | +19.4% | 8,935 | 0.0% | 0.01% | +16.7% |
Q2 2020 | $1,104,000 | +28.1% | 8,935 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $862,000 | -6.1% | 8,935 | -10.1% | 0.01% | +20.0% |
Q4 2019 | $918,000 | +20.6% | 9,935 | 0.0% | 0.01% | +25.0% |
Q3 2019 | $761,000 | -15.6% | 9,935 | -5.4% | 0.00% | -20.0% |
Q2 2019 | $902,000 | +45.5% | 10,500 | 0.0% | 0.01% | +25.0% |
Q1 2019 | $620,000 | +12.1% | 10,500 | 0.0% | 0.00% | +33.3% |
Q4 2018 | $553,000 | -5.0% | 10,500 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $582,000 | +18.1% | 10,500 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $493,000 | +30.1% | 10,500 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $379,000 | -0.3% | 10,500 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $380,000 | +10.5% | 10,500 | +16.7% | 0.00% | 0.0% |
Q3 2017 | $344,000 | -2.3% | 9,000 | +5.9% | 0.00% | 0.0% |
Q2 2017 | $352,000 | +17.7% | 8,500 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $299,000 | +14.6% | 8,500 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $261,000 | -13.3% | 8,500 | -15.0% | 0.00% | 0.0% |
Q3 2016 | $301,000 | -22.8% | 10,000 | -29.9% | 0.00% | 0.0% |
Q2 2016 | $390,000 | +2.1% | 14,275 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $382,000 | +35.5% | 14,275 | +42.8% | 0.00% | 0.0% |
Q4 2015 | $282,000 | -15.6% | 10,000 | -16.7% | 0.00% | 0.0% |
Q3 2015 | $334,000 | -32.5% | 12,000 | 0.0% | 0.00% | -33.3% |
Q2 2015 | $495,000 | +63.4% | 12,000 | +20.0% | 0.00% | +50.0% |
Q1 2015 | $303,000 | +27.8% | 10,000 | -16.7% | 0.00% | +100.0% |
Q4 2014 | $237,000 | -0.4% | 12,000 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $238,000 | -12.8% | 12,000 | 0.0% | 0.00% | -50.0% |
Q2 2014 | $273,000 | – | 12,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |